NM_012123.4:c.1894C>T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_012123.4(MTO1):​c.1894C>T​(p.Leu632Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00818 in 1,612,248 control chromosomes in the GnomAD database, including 92 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0049 ( 3 hom., cov: 30)
Exomes 𝑓: 0.0085 ( 89 hom. )

Consequence

MTO1
NM_012123.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.549

Publications

5 publications found
Variant links:
Genes affected
MTO1 (HGNC:19261): (mitochondrial tRNA translation optimization 1) This gene encodes a mitochondrial protein thought to be involved in mitochondrial tRNA modification. The encoded protein may also play a role in the expression of the non-syndromic and aminoglycoside-induced deafness phenotypes associated with a specific mutation in the mitochondrial 12S rRNA gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
EEF1A1 (HGNC:3189): (eukaryotic translation elongation factor 1 alpha 1) This gene encodes an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas, and the other isoform (alpha 2) is expressed in brain, heart and skeletal muscle. This isoform is identified as an autoantigen in 66% of patients with Felty syndrome. This gene has been found to have multiple copies on many chromosomes, some of which, if not all, represent different pseudogenes. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 6-73497873-C-T is Benign according to our data. Variant chr6-73497873-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 138277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.549 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00495 (753/152222) while in subpopulation NFE AF = 0.0092 (626/68024). AF 95% confidence interval is 0.00861. There are 3 homozygotes in GnomAd4. There are 321 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTO1NM_012123.4 linkc.1894C>T p.Leu632Leu synonymous_variant Exon 11 of 12 ENST00000498286.6 NP_036255.2 Q9Y2Z2-4
MTO1NM_001123226.2 linkc.2014C>T p.Leu672Leu synonymous_variant Exon 12 of 13 NP_001116698.1 Q9Y2Z2-6
MTO1NM_133645.3 linkc.1969C>T p.Leu657Leu synonymous_variant Exon 12 of 13 NP_598400.1 Q9Y2Z2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTO1ENST00000498286.6 linkc.1894C>T p.Leu632Leu synonymous_variant Exon 11 of 12 1 NM_012123.4 ENSP00000419561.2 Q9Y2Z2-4

Frequencies

GnomAD3 genomes
AF:
0.00495
AC:
753
AN:
152104
Hom.:
3
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00159
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00920
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00497
AC:
1248
AN:
251042
AF XY:
0.00467
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00255
Gnomad ASJ exome
AF:
0.000596
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00144
Gnomad NFE exome
AF:
0.00894
Gnomad OTH exome
AF:
0.00425
GnomAD4 exome
AF:
0.00852
AC:
12433
AN:
1460026
Hom.:
89
Cov.:
30
AF XY:
0.00811
AC XY:
5886
AN XY:
726150
show subpopulations
African (AFR)
AF:
0.00146
AC:
49
AN:
33462
American (AMR)
AF:
0.00284
AC:
127
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.000460
AC:
12
AN:
26082
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39650
South Asian (SAS)
AF:
0.00193
AC:
166
AN:
86126
European-Finnish (FIN)
AF:
0.00173
AC:
92
AN:
53290
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5764
European-Non Finnish (NFE)
AF:
0.0104
AC:
11546
AN:
1110640
Other (OTH)
AF:
0.00723
AC:
436
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
587
1174
1762
2349
2936
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
452
904
1356
1808
2260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00495
AC:
753
AN:
152222
Hom.:
3
Cov.:
30
AF XY:
0.00431
AC XY:
321
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.00159
AC:
66
AN:
41536
American (AMR)
AF:
0.00216
AC:
33
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4824
European-Finnish (FIN)
AF:
0.00113
AC:
12
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00920
AC:
626
AN:
68024
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
42
83
125
166
208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00680
Hom.:
6
Bravo
AF:
0.00503
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00855
EpiControl
AF:
0.00771

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 21, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 02, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MTO1: BP4, BP7, BS1, BS2 -

not specified Benign:1
Jan 25, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
5.3
DANN
Benign
0.63
PhyloP100
0.55
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117757245; hg19: chr6-74207596; API